Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer dur...
Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy
About this item
Full title
Author / Creator
Chen, Zhuxing , Liu, Liping , Zhu, Feng , Cai, Xiuyu , Zhao, Yi , Liang, Peng , Ou, Limin , Zhong, Ran , Yu, Ziwen , Li, Caichen , Li, Jianfu , Xiong, Shan , Feng, Yi , Cheng, Bo , Liang, Hengrui , Xie, Zhanhong , Liang, Wenhua and He, Jianxing
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
To reveal the correlation of dynamic serum tumor markers (STMs) and molecular features of epidermal growth factor receptor‐mutated (EGFR‐mutated) lung cancer during targeted therapy, we retrospectively reviewed 303 lung cancer patients who underwent dynamic STM tests [neuron‐specific enolase (NSE), carcinoembryonic antigen (CEA), carbohydrate antig...
Alternative Titles
Full title
Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_982e3c0cb209479285198b6afdf32ca8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_982e3c0cb209479285198b6afdf32ca8
Other Identifiers
ISSN
2045-7634
E-ISSN
2045-7634
DOI
10.1002/cam4.4676
